GS-5759
GS-5759 is a novel small molecule therapeutic candidate for Chronic Obstructive Pulmonary Disease (COPD) research. It combines β2-adrenergic receptor agonism with phosphodiesterase 4 (PDE4) inhibition in a single agent, offering a unique dual mechanism of action. This bifunctional profile is investigated in vitro and in vivo for its potential to enhance bronchodilation and suppress inflammation concurrently.
Product Specifications
CAS Number
1346653-91-5
Smiles
COc1cccc (Nc2c (cnc3c (C) cc (cc23) S (=O) (=O) c2cccc (c2) C (=O) Nc2ccc (cc2) C#CCCCNC[C@H] (O) c2ccc (O) c3[nH]c (=O) ccc23) C (N) =O) c1
Molecular Formula
C47H42N6O8S
Molecular Weight
850.947
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6394403-01 0.1 mL
SLURP1 (Secreted Ly-6/uPAR-related Protein 1, SLURP-1, Anti-neoplastic Urinary Protein, ANUP, ARS Component B, ArsB, ARS(component B)-81/S, ARS, LY6LS, MDM) (HRP)
Sign In for Pricing
View Details MBS6394403-02 5x 0.1 mL
SLURP1 (Secreted Ly-6/uPAR-related Protein 1, SLURP-1, Anti-neoplastic Urinary Protein, ANUP, ARS Component B, ArsB, ARS(component B)-81/S, ARS, LY6LS, MDM) (HRP)
Sign In for Pricing
View Details